ABCF2

ATP-binding cassette sub-family F member 2 · Q9UG63 · ABCF2 on Sugi Atlas →

0 patent compounds predicted against ABCF2, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to ABCF2 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
R230C and C230C Variants of ABCA1 and Glyburide Response PHASE4COMPLETED
Paclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer PHASE3COMPLETED
A Phase 2 Trial of SCO-101 in Combination With FOLFIRI for Patients With Metastatic Colorectal Cancer (mCRC) With Acquired Resistance to FOLFIRI PHASE1/PHASE2UNKNOWN
The Evaluation of the Drug R3R01 for the Excretion of Protein in the Urine in Patients With Diabetic Kidney Disease. PHASE2RECRUITING
Clofarabine and Cytarabine in Treating Young Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia PHASE1/PHASE2COMPLETED
Everolimus (RAD001) for Children With Chemotherapy-Refractory Progressive or Recurrent Low-Grade Gliomas PHASE2COMPLETED
A Study of ABC294640 Alone and in Combination With HCQ Sulfate in the Treatment of Advanced Cholangiocarcinoma PHASE2COMPLETED
Surgery Plus Chemotherapy (Doxorubicin, Vincristine and Etoposide), Mitotane, and Tariquidar to Treat Adrenocortical Cancer PHASE2COMPLETED
Influence of Ethnicity and ABCB1 Gene Polymorphism on the Pharmacokinetics of Azithromycin in Healthy Bangladeshi Volunteers PHASE1UNKNOWN
Indenoisoquinoline LMP744 in Adults With Relapsed Solid Tumors and Lymphomas PHASE1COMPLETED
Icotinib Hydrochloride in Treating Patients With Advanced Cancers PHASE1WITHDRAWN
Efavirenz for Patients With Alzheimer's Disease PHASE1COMPLETED
Bile Acids Metabolism and Genetic Mutation Profile in the Intrahepatic Cholestasis of Pregnacy in Indian Population nanRECRUITING
the Effect of ABCC2 Genetic Polymorphism on Neurotoxicity in Gastrointestinal Cancer Patients Receiving Oxaliplatin nanUNKNOWN
Multidrug Resistance Genes in Patients With Acute Myeloid Leukemia nanACTIVE_NOT_RECRUITING
Coproporphyrine Isomers and Methotrexate Elimination nanCOMPLETED
Hydroxychloroquin (HCQ) in chILD of Genetic Defect nanCOMPLETED
Genetic Causes and Clinical Features of Childhood Interstitial Lung Diseases in China nanCOMPLETED
Ezetimibe Utilization Early After Acute Myocardial Infarction, EzAMI Trial nanRECRUITING
Placental Transfer of Tenofovir nanCOMPLETED
Genetic Polymorphisms of ABCB11 and ABCB4 in Women With Intrahepatic Cholestasis of Pregnancy (ICP) and in Their First Degree Relatives nanUNKNOWN
Study of Blood and Cheek Cell Samples From Patients With Glioma nanCOMPLETED
The Association of SAA With Apolipoprotein B Affects Cardiovascular Risk nanCOMPLETED
Effect of Pharmacogenetics on Imatinib Plasma Level and Response nanCOMPLETED
The Genetic, Protein, and Lipid Basis of Variation in Cholesterol Efflux nanCOMPLETED
High-Density Lipoprotein (HDL) Treatment Study nanCOMPLETED
National Active Surveillance Network and Pharmacogenomics of Adverse Drug Reactions in Children nanRECRUITING
Study of ABCB1,SLC22A16 Drug Transporter Genes and Doxorubicin and Cyclophosphamide Toxicity in Brest Cancer Patient nanUNKNOWN
Ginger and Plasma Cholesterol Efflux Capacity nanCOMPLETED
Role of Sorcin and Annexin A3 in Breast Cancer Patients nanUNKNOWN

Related proteins — ESM-2 sequence neighbours (a ABCF2 binder may also engage these)

ProteinNameSimilarity
Q2KJA2 1.000 Q2KJA2 →
Q99LE6 1.000 Q99LE6 →
Q9FJH6 1.000 Q9FJH6 →
Q8H0V6 1.000 Q8H0V6 →
Q8T6B7 0.999 Q8T6B7 →
P40024 0.995 P40024 →
O42943 0.994 O42943 →
Q8K268 0.994 Q8K268 →
Q9M1H3 0.994 Q9M1H3 →
Q5R9Z5 0.992 Q5R9Z5 →
Q66H39 0.992 Q66H39 →
O94489 0.992 O94489 →
O14134 0.992 O14134 →
O59672 0.991 O59672 →
A0A139AVY4 0.990 A0A139AVY4 →
Q9NUQ8 0.989 Q9NUQ8 →
P43535 0.989 P43535 →
Q6MG08 0.989 Q6MG08 →
Q767L0 0.988 Q767L0 →
D0MYB4 0.988 D0MYB4 →
P29551 0.988 P29551 →
Q9FIB4 0.988 Q9FIB4 →
Q6P542 0.988 Q6P542 →
P34647 0.988 P34647 →
A0A0D1CLQ4 0.987 A0A0D1CLQ4 →
P53978 0.987 P53978 →
Q9LV93 0.987 Q9LV93 →
Q7YR37 0.987 Q7YR37 →
A0A0H2VFI8 0.986 A0A0H2VFI8 →
B4NBB0 0.986 B4NBB0 →